Your browser doesn't support javascript.
loading
Effect of ABCG2, OCT1, and ABCB1 (MDR1) Gene Expression on Treatment-Free Remission in a EURO-SKI Subtrial.
Rinaldetti, Sébastien; Pfirrmann, Markus; Manz, Kirsi; Guilhot, Joelle; Dietz, Christian; Panagiotidis, Panayiotidis; Spiess, Birgit; Seifarth, Wolfgang; Fabarius, Alice; Müller, Martin; Pagoni, Maria; Dimou, Maria; Dengler, Jolanta; Waller, Cornelius F; Brümmendorf, Tim H; Herbst, Regina; Burchert, Andreas; Janßen, Carsten; Goebeler, Maria Elisabeth; Jost, Philipp J; Hanzel, Stefan; Schafhausen, Philippe; Prange-Krex, Gabriele; Illmer, Thomas; Janzen, Viktor; Klausmann, Martine; Eckert, Robert; Büschel, Gerd; Kiani, Alexander; Hofmann, Wolf-Karsten; Mahon, François-Xavier; Saussele, Susanne.
Afiliação
  • Rinaldetti S; Department of Hematology and Oncology, University Hospital Mannheim, Heidelberg University, Mannheim, Germany. Electronic address: sebastien.rinaldetti@medma.uni-heidelberg.de.
  • Pfirrmann M; Institut für Medizinische Informationsverarbeitung, Biometrie und Epidemiologie (IBE), Ludwig-Maximilians-Universität, München, Germany.
  • Manz K; Institut für Medizinische Informationsverarbeitung, Biometrie und Epidemiologie (IBE), Ludwig-Maximilians-Universität, München, Germany.
  • Guilhot J; INSERM CIC 1402, CHU de Poitiers, Poitiers, France.
  • Dietz C; Institute for Hematology and Oncology (IHO GmbH), Mannheim, Germany.
  • Panagiotidis P; Laikon General Hospital, National and Kapodistrian University of Athens, Athens, Greece.
  • Spiess B; Department of Hematology and Oncology, University Hospital Mannheim, Heidelberg University, Mannheim, Germany.
  • Seifarth W; Department of Hematology and Oncology, University Hospital Mannheim, Heidelberg University, Mannheim, Germany.
  • Fabarius A; Department of Hematology and Oncology, University Hospital Mannheim, Heidelberg University, Mannheim, Germany.
  • Müller M; Institute for Hematology and Oncology (IHO GmbH), Mannheim, Germany.
  • Pagoni M; Evangelismos Hospital, Athens, Greece.
  • Dimou M; Laikon General Hospital, National and Kapodistrian University of Athens, Athens, Greece.
  • Dengler J; Onkologische Schwerpunktpraxis Heilbronn, Heilbronn, Germany.
  • Waller CF; Innere Medizin I, Universitätsklinikum Freiburg, Freiburg, Germany.
  • Brümmendorf TH; Uniklinik RWTH Aachen, Aachen, Germany.
  • Herbst R; Klinik für Innere Medizin III, Klinikum Chemnitz, Chemnitz, Germany.
  • Burchert A; Klinik für Innere Medizin, Schwerpunkt Hämatologie, Onkologie und Immunologie, Universitätsklinikum Marburg, Marburg, Germany.
  • Janßen C; Onkologie untere Ems, Leer, Germany.
  • Goebeler ME; Medizinische Klinik und Poliklinik, Universitätsklinikum Würzburg, Würzburg, Germany.
  • Jost PJ; III. Medizinische Klinik, Klinikum rechts der Isar, Technische Universität, München, Germany.
  • Hanzel S; Hämatologie, Onkologie und Palliativmedizin, Klinikverbund Kempten-Oberallgäu, Kempten, Germany.
  • Schafhausen P; II. Medizinische Klinik und Poliklinik, Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany.
  • Prange-Krex G; Gemeinschaftspraxis Dres Mohm und Prange-Krex, Dresden, Germany.
  • Illmer T; Fachärztliche Gemeinschaftspraxis mit Schwerpunkt Hämatologie und Onkologie, Dresden, Germany.
  • Janzen V; Medizinische Klinik und Poliklinik III, Universitätsklinikum Bonn, Bonn, Germany.
  • Klausmann M; Gemeinschaftspraxis Drs Klausmann, Aschaffenburg, Germany.
  • Eckert R; Onkologische Schwerpunktpraxis Esslingen, Esslingen, Germany.
  • Büschel G; Hämatologie, Onkologie und Palliativmedizin, Vivantes Klinikum Neuköln, Berlin, Germany.
  • Kiani A; Klinik für Onkologie und Hämatologie, Klinikum Bayreuth, Bayreuth, Germany.
  • Hofmann WK; Department of Hematology and Oncology, University Hospital Mannheim, Heidelberg University, Mannheim, Germany.
  • Mahon FX; Bergonié Cancer Institute, INSERM Unit 916, University of Bordeaux, Bordeaux, France.
  • Saussele S; Department of Hematology and Oncology, University Hospital Mannheim, Heidelberg University, Mannheim, Germany.
Clin Lymphoma Myeloma Leuk ; 18(4): 266-271, 2018 04.
Article em En | MEDLINE | ID: mdl-29510895
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Mielogênica Crônica BCR-ABL Positiva / Biomarcadores Tumorais / Variantes Farmacogenômicos / Antineoplásicos Tipo de estudo: Clinical_trials / Guideline / Prognostic_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Lymphoma Myeloma Leuk Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Mielogênica Crônica BCR-ABL Positiva / Biomarcadores Tumorais / Variantes Farmacogenômicos / Antineoplásicos Tipo de estudo: Clinical_trials / Guideline / Prognostic_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Lymphoma Myeloma Leuk Ano de publicação: 2018 Tipo de documento: Article